Literature DB >> 9164669

The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments.

R Mongeau1, P Blier, C de Montigny.   

Abstract

Previous reviews have well illustrated how antidepressant treatments can differentially alter several neurotransmitter systems in various brain areas. This review focuses on the effects of distinct classes of antidepressant treatments on the serotonergic and the noradrenergic systems of the hippocampus, which is one of the brain limbic areas thought to be relevant in depression: it illustrates the complexity of action of these treatments in a single brain area. First, the basic elements (receptors, second messengers, ion channels, ...) of the serotonergic and noradrenergic systems of the hippocampus are revisited and compared. Second, the extensive interactions occurring between the serotonergic and the noradrenergic systems of the brain are described. Finally, issues concerning the short- and long-term effects of antidepressant treatments on these systems are broadly discussed. Although there are some contradictions, the bulk of data suggests that antidepressant treatments work in the hippocampus by increasing and decreasing, respectively, serotonergic and noradrenergic neurotransmission. This hypothesis is discussed in the context of the purported function of the hippocampus in the formation of memory traces and emotion-related behaviors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9164669     DOI: 10.1016/s0165-0173(96)00017-3

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  51 in total

1.  The involvement of intracerebral monoamines in the development of intracellular process in neocortex neurons.

Authors:  V A Otellin; A A Neokesariiskii; D E Korzhevskii
Journal:  Neurosci Behav Physiol       Date:  1999 Nov-Dec

2.  The effect of the serotonergic receptor antagonist mianserine on the activity of Na, K-ATPase from rat cerebral cortex membranes.

Authors:  P A Erokhov; B N Manukhin
Journal:  Dokl Biol Sci       Date:  2002 Jul-Aug

3.  Associations between the serotonin-1A receptor C(-1019)G polymorphism and disordered eating symptoms in female adolescents.

Authors:  Se-Won Lim; Juwon Ha; Dong-Won Shin; Hee-Yeon Woo; Kye-Hyun Kim
Journal:  J Neural Transm (Vienna)       Date:  2010-05-09       Impact factor: 3.575

4.  Effects of sustained (+/-)pindolol administration on serotonin neurotransmission in rats.

Authors:  N Haddjeri; P Blier
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

Review 5.  Preclinical studies modeling deep brain stimulation for depression.

Authors:  Clement Hamani; José N Nobrega
Journal:  Biol Psychiatry       Date:  2012-06-29       Impact factor: 13.382

6.  Deep brain stimulation reverses anhedonic-like behavior in a chronic model of depression: role of serotonin and brain derived neurotrophic factor.

Authors:  Clement Hamani; Danilo C Machado; Débora C Hipólide; Francisco P Dubiela; Deborah Suchecki; Carlos E Macedo; Fabio Tescarollo; Uilton Martins; Luciene Covolan; José N Nobrega
Journal:  Biol Psychiatry       Date:  2011-10-14       Impact factor: 13.382

Review 7.  Translational and reverse translational research on the role of stress in drug craving and relapse.

Authors:  Rajita Sinha; Yavin Shaham; Markus Heilig
Journal:  Psychopharmacology (Berl)       Date:  2011-04-15       Impact factor: 4.530

8.  Vagus nerve stimulation potentiates hippocampal LTP in freely-moving rats.

Authors:  Yantao Zuo; Douglas C Smith; Robert A Jensen
Journal:  Physiol Behav       Date:  2007-01-03

9.  Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta.

Authors:  E Sterneck; R Paylor; V Jackson-Lewis; M Libbey; S Przedborski; L Tessarollo; J N Crawley; P F Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol.

Authors:  A D Lê; S Harding; W Juzytsch; P J Fletcher; Y Shaham
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.